CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more


Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Promising results from implanted drug reservoir for wet AMD

A clinical trial involving 220 patients has found that an implant that continuously delivers medication into the eye is safe and effective

Elderly man close up

A port delivery system that continuously delivers medication into the eye could provide an alternative to regular injections for wet age-related macular degeneration (AMD).

New research, which was published in Ophthalmology, describes the results of a clinical trial with 220 wet AMD patients.

Scientists report that the drug delivery implant had comparable visual outcomes to monthly intravitreal injections.

They emphasised that the technology has the potential to reduce the treatment burden of wet AMD while maintaining vision.

Dr Peter Campochiaro, from the Wilmer Eye Institute, highlighted that missed injection appointments can lead to an irreversible decline in vision.

“This study shows that the implant is safe and effective and may only require a clinic visit and refill every six months,” he said.

Clinicians can replace medication in the reservoir without removing the implant.

Image credit: Pixabay